Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
Loading SNTA News...
Health Technology » Pharmaceuticals Other
|VRX||Valeant Pharmaceuticals International, Inc.||-1.32%||14.91||8.4%||$220.21m|
|SHPG||Shire PLC Sponsored ADR||-1.38%||164.11||0.3%||$168.35m|
|PRGO||Perrigo Co. Plc||0.03%||76.48||3.6%||$128.67m|
|JAZZ||Jazz Pharmaceuticals Plc||-3.26%||124.42||2.2%||$91.43m|
|UTHR||United Therapeutics Corporation||0.42%||153.44||17.3%||$91.08m|
|ENDP||Endo International Plc||-2.05%||12.90||6.3%||$75.86m|
|ICPT||Intercept Pharmaceuticals, Inc.||-0.98%||114.67||19.7%||$63.79m|
|PCRX||Pacira Pharmaceuticals, Inc.||3.41%||40.95||11.1%||$58.24m|
|PRXL||PAREXEL International Corporation||-0.14%||70.90||8.2%||$46.38m|
|SGYP||Synergy Pharmaceuticals, Inc.||-1.84%||6.41||14.6%||$45.70m|
|HZNP||Horizon Pharma plc||-1.52%||16.86||11.5%||$44.70m|
|PTLA||Portola Pharmaceuticals, Inc.||-0.66%||25.42||9.1%||$41.94m|
|GWPH||GW Pharmaceuticals PLC Sponsored ADR||-2.98%||118.65||10.5%||$39.76m|
Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA.